Financials

Q2 2017

Revenue increased by 6.3%, hereof 5.3% organic, to DKK 1,404m in reported currencies and by 6.2% in constant currencies. Revenue increased by 15% from customers outside the Novo Nordisk Group while revenue from the Novo Nordisk Group decreased by 3.4%. Operating profit margin was 9.5% in reported currencies and 9.4% in constant currencies compared to 9.6% as reported in 6M 2016.

Expected revenue growth is maintained at 4-8% in constant currencies with expected organic growth of 1-5%. Operating profit margin is maintained to be around 10% in constant currencies. The expected level of investments in 2017 is 15-17% with an expected organic investment level of 12-14% of total revenue as the majority of investment related to an additional data center will impact 2017. The Board of Directors has decided to pay an interim dividend for 2017 of DKK 2.00 per share corresponding to DKK 48.7m.

“NNIT continues the positive development for 2017 where we deliver robust IT and generate growth, driven by clients outside the Novo Nordisk Group which grew with more than 17% in Q2. I am particularly pleased to see several new orders within Dynamics 365 won by our newly acquired company SCALES.“

Per Kogut, Chief Executive Officer (CEO)

Investor relations contact

Jesper Wagener
Head of Investor Relations

Email
+45 3075 5392

Email alerts

To subscribe to receive updates by email.

Subscribe

Follow NNIT